Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Roques

Showing results (261-270 of 558) with videos related to

Pageof 56
Sort By:
Biochemistry|September 5, 1989
Delta opioid receptor selectivity induced by conformational constraints in linear enkephalin-related peptides: 1H 400-MHz NMR study and theoretical calculationsJ Belleney, G Gacel, M C Fournié-Zaluski, et al.
Biochemistry|July 28, 1999
Structural investigation on the requirement of CCHH zinc finger type in nucleocapsid protein of human immunodeficiency virus 1S Ramboarina, N Morellet, M C Fournié-Zaluski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 6, 1999
Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulationA Sebret, I Léna, D Crété, et al.
British Journal of Pharmacology|June 16, 2001
Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker ratV Arbin, N Claperon, M C Fournié-Zaluski, et al.
Life Sciences|August 27, 1984
Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymesR Bouboutou, G Waksman, J Devin, et al.
European Journal of Pharmacology|March 3, 1994
Assessment of physical dependence after continuous perfusion into the rat jugular vein of the mixed inhibitor of enkephalin-degrading enzymes, RB 101F Noble, P Coric, S Turcaud, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991
Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanismJ N Crawley, S M Fiske, C Durieux, et al.
The Biochemical Journal|April 15, 1990
Recombinant neutral endopeptidase-24.11 expressed in mouse neuroblastoma cells is associated with neurite membranesG Lemay, M Zollinger, G Waksman, et al.
Protein Engineering|October 31, 1998
Model of the complex formed between the H2 domain of the TATA box binding protein and the L(281-301) fragment of the human transcription factor TFIIAS Ramboarina, N Morellet, P Petitjean, et al.
European Journal of Clinical Investigation|November 1, 1996
Characterization of a soluble form of neutral endopeptidase-24.11 (EC 3.4.24.11) in human serum: enhancement of its activity in serum of underground miners exposed to coal dust particlesJ M Soleilhac, C Lafuma, J M Porcher, et al.
Pageof 56

Showing results (261-270 of 558) with videos related to

Sort By:
Pageof 56
Biochemistry|September 5, 1989
Delta opioid receptor selectivity induced by conformational constraints in linear enkephalin-related peptides: 1H 400-MHz NMR study and theoretical calculationsJ Belleney, G Gacel, M C Fournié-Zaluski, et al.
Biochemistry|July 28, 1999
Structural investigation on the requirement of CCHH zinc finger type in nucleocapsid protein of human immunodeficiency virus 1S Ramboarina, N Morellet, M C Fournié-Zaluski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 6, 1999
Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulationA Sebret, I Léna, D Crété, et al.
British Journal of Pharmacology|June 16, 2001
Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker ratV Arbin, N Claperon, M C Fournié-Zaluski, et al.
Life Sciences|August 27, 1984
Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymesR Bouboutou, G Waksman, J Devin, et al.
European Journal of Pharmacology|March 3, 1994
Assessment of physical dependence after continuous perfusion into the rat jugular vein of the mixed inhibitor of enkephalin-degrading enzymes, RB 101F Noble, P Coric, S Turcaud, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991
Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanismJ N Crawley, S M Fiske, C Durieux, et al.
The Biochemical Journal|April 15, 1990
Recombinant neutral endopeptidase-24.11 expressed in mouse neuroblastoma cells is associated with neurite membranesG Lemay, M Zollinger, G Waksman, et al.
Protein Engineering|October 31, 1998
Model of the complex formed between the H2 domain of the TATA box binding protein and the L(281-301) fragment of the human transcription factor TFIIAS Ramboarina, N Morellet, P Petitjean, et al.
European Journal of Clinical Investigation|November 1, 1996
Characterization of a soluble form of neutral endopeptidase-24.11 (EC 3.4.24.11) in human serum: enhancement of its activity in serum of underground miners exposed to coal dust particlesJ M Soleilhac, C Lafuma, J M Porcher, et al.
Pageof 56